Synthesis and Study of Antibacterial and Antifungal Activities of Novel 2-[[(Benzoxazole/benzimidazole-2-yl)sulfanyl]acetylamino]thiazoles |
Kaplancikli, Zafer-Asim
(Anadolu University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry)
Gulhan, Turan-Zitouni (Anadolu University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry) Revial, Gilbert (Laboiratoire de Chimie Organique, CNRS (ESA 7084) ESPCI) Guven, Kiymet (Anadolu University, Faculty of Science, Department of Biology) |
1 | Perrin, L., Rakik, A., Yerly, S., Baumberger, C., Kinlochde-Loes, S., Pechere, M., and Hirschel, B., Combined therapy with zidovudine and L-697,661 in primary HIV infection. AIDS, 10, 1233-1237 (1996) DOI PUBMED ScienceOn |
2 | Rapp, R. P., Antimicrobial resistance in gram-positive bacteria: The myth of the MIC. Pharmacotherapy, 19, 112-119 (1999) DOI |
3 | Rybak, M. J. and Akins, R. L., Emergence of methicillin-resistant Staphylococcus aureus with intermediate glycopeptide resistance-Clinical significance and treatment options. Drugs, 6,1-7 (2001) DOI PUBMED ScienceOn |
4 | Alexander, B. D. and Perfect, J. R., Antifungal resistance trends towards the year 2000 Implications for therapy and new approaches. Drugs, 54, 657-678 (1997) DOI ScienceOn |
5 | Ates, O., Altintas, H. and Otuk, G., Synthesis and antimicrobial activity of 4-carbethoxymethyl-2-[(alpha-haloacyl)amino]thiazoles and 5-nonsubstituted/stituted 2-[(4-carbethoxy-methylthiazol-2-yl)imino]-4-thiazolidinones. Arzneim. Forsch., 50, 569-575 (2000). |
6 | Doern, G. V., Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. Clin. lnfect. Dis., 33,187-192 (2001) DOI ScienceOn |
7 | Hood, S. and Denning, D. W., Treatment of fungal infection in AIDS, J. Antimicrob. Chemoth., 37, 71-85 (1996) |
8 | Joule, J. A. and Mills, K., Heterocyclic Chemistry, Blackwell Science Ltd., Oxford, (2000) |
9 | Kim J. S., Sun, Q., Gatto, B., Yu, C., Liu, A., Liu, L. F., and LaVoie, E. J., Structure-activity relationships of benzimidazoles and related heterocycles as topoisomerase I poisons. Bioorg. Med. Chem., 4, 621-630 (1996) DOI ScienceOn |
10 | Levy, S. B., The challenge of antibiotic resistance. Sci. Am., 278, 46-53 (1998) PUBMED |
11 | Lakhan, R., Sharma, B. P., and Shukla, B. N., Synthesis and antimicrobial activity of 1-aryl-2-amino-3-(4-arylthiazol-2-yl)/(benzothiazol-2-yl)guanidines. Farmaco, 55, 331-337 (2000) DOI ScienceOn |
12 | Cetinkaya, Y., Falk, P., and Mayhall, C.G., Vancomycin-resistant enterococci. Clin. Microbiol. Rev., 13, 686-707 (2000) DOI ScienceOn |
13 | Gringauz, A., Introduction to Medicinal Chemistry, How Drug Act and Why., Wiley-VCH Inc., USA (1997) |
14 | Hubschwerlen, C., Pflieger, P., Specklin, J. L., Gubernator, K., Gmunder, H., Angehrn, P., and Kompis, I., Pyrimido[1,6-a]benzimidazoles: a new class of DNA gyrase inhibitors. J. Med. Chem., 35, 1385-1392 (1992) DOI PUBMED |
15 | Pandeya, S. N., Sriram, D., and Nath, G., Synthesis, antibacterial, antifungal and anti-HIV activities of Schiff and Mannich bases derived from isatin derivatives and N-[4-(4'-chlorophenyl)thiazol-2-yl] thiosemicarbazide. Eur. J. Pharm. Sci., 9, 25-31 (1999) DOI ScienceOn |
16 | Turan-Zitouni, G. and Kaplancikli, Z. A., Some new 2,3-dihydro-3-benzofuranamine derivatives. Boll. Chim. Farmaceutico, 137, 367-371 (1998) |
17 | Cunha, B. A., Antibiotic resistance. Drugs Today, 34, 691-698 (1998) DOI PUBMED |
18 | Koneman, E. W., Allen, S. D., and Winn, W. C., Colour Atlas and Textbook of Diagnostic Microbiology, Lippincott Raven Pub., Philadelphia, (1997) |
19 | Goodman-Gilman, A., The pharmacological basis of therapeutics. McGraw-Hill company, USA, (2001) |
20 | Marchese, A., Schito, G. C., and Debbia, E. A, Evolution of antibiotic resistance in gram-positive pathogens. J. Chemotherapy, 12, 459-462 (2000) DOI |
21 | Amyes, S. G. B. and Gemmell, C. G., Antibiotic resistance Proceedings of a symposium held on 12 July 1996 at the University of Southampton. J. Med. Microbiol., 46, 436-470(1997) DOI ScienceOn |
22 | Healy, V. L., Lessard, I. A. D., Roper, D. I., Knox, J. R. and Walsh, C. T., Vancomycin resistance in enterococci: reprogramming of the D-Ala-D-Ala ligases in bacterial peptidoglycan biosynthesis. Chem. Biol., 7, 109-119 (2000) DOI ScienceOn |
23 | Lipsitch, M., The rise and fall of antimicrobial resistance. Trends Microbiol., 9, 438-444 (2001) DOI PUBMED ScienceOn |
24 | Thompson, L. A. and Ellman, J. A., Synthesis and applications of small molecule libraries. Chem. Rev., 96, 555-600 (1996) DOI ScienceOn |
25 | Turan-Zitouni, G., Demirayak, S., Ozdemir, A., Kaplancikli, Z. A., and Yildiz, M. T., Synthesis of some 2-[(benzazole-2yl)thioacetylamino]thiazole derivatives and their antimicrobial activity and toxicity. Eur. J. Med. Chem., 39, 267-272 (2004) DOI ScienceOn |
26 | Cassell, G. H. and Mekalanos, J., Development of antimicrobial agents in the era of new and reemerging infectious diseases and increasing antibiotic resistance. J. Am. Med. Assoc., 285, 601-605 (2001) DOI ScienceOn |
27 | Silverman, R. B., Organic chemistry of Drug Desing and Drug Action, Academic press, San Diego, (1992) |
28 | Lopez-Garcia, B., Veyrat, A., Perez-Paya, E., Gonzalez-Candelas, L., and Marcos, J. F., Comparison of the activity of antifungal hexapeptides and the fungicides thiabendazole and imazalil against postharvest fungal pathogens. Int. J. Food Microbiol., 89, 163-170, (2003) DOI PUBMED ScienceOn |
29 | Chu, D. T. W., Plattner, J. J., and Katz, L., New directions in antibacterial research. J. Med. Chem., 39, 3853-3874 (1996) DOI ScienceOn |
30 | Onoe, H. and Takahashi, H., Jpn. Kokai. Tokkyo Koho JP 03 87,841 (1994). Chem. Abstr., 121,205336 (1994) |